Table of contents

Extended reports

• Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative (26 August, 2005)

  F Eckstein, M Hudelmaier, W Wirth, B Kiefer, R Jackson, J Yu, C B Eaton, E Schneider
• ASAS/EULAR recommendations for the management of ankylosing spondylitis (26 August, 2005) Free

  J Zochling, D van der Heijde, R Burgos-Vargas, E Collantes, J C Davis, B Dijkmans, M Dougados, P Géher, R D Inman, M A Khan, T K Kvien, M Leirisalo-Repo, I Olivieri, K Pavelka, J Sieper, G Stucki, R D Sturrock, S van der Linden, D Wendling, H Böhm, B J van Royen, J Braun
• Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset (21 September, 2005)

  E Berglin, T Johansson, U Sundin, E Jidell, G Wadell, G Hallmans, S Rantapää-Dahlqvist
• Use of digital x ray radiogrammetry in the assessment of joint damage in rheumatoid arthritis

  (26 August, 2005)

  W B Jawaid, D Crosbie, J Shotton, D M Reid, A Stewart
• Methotrexate modulates the kinetics of adenosine in humans in vivo (24 November, 2005) Free

  N P Riksen, P Barrera, P H H van den Broek, P L C M van Riel, P Smits, G A Rongen
• Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis (11 August, 2005)

  A Kavanaugh, C Antoni, G G Krueger, S Yan, M Bala, L T Dooley, A Beutler, C Guzzo, D Gladman
• Clinical and radiological damage in psoriatic arthritis (26 August, 2005)

  F Siannis, V T Farewell, R J Cook, C T Schentag, D D Gladman
• Analysis of RAG expression by peripheral blood CD5+ and CD5− B cells of patients with childhood systemic lupus erythematosus (26 August, 2005)

  H Morbach, S K Singh, C Faber, P E Lipsky, H J Girschick
• MHC class II, tumour necrosis factor α, and lymphotoxin α gene haplotype associations with serological subsets of systemic lupus erythematosus (17 August, 2005)

  N J McHugh, P Owen, B Cox, J Dunphy, K Welsh
• An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus (8 September, 2005)

  M-C Zhang, N Misu, H Furukawa, Y Watanabe, M Terada, H Komori, T Miyazaki, M Nose, M Ono
• Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography (8 September, 2005)

  N J Peake, H E Foster, K Khawaja, T E Cawston, A D Rowan
• A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease (26 August, 2005)

  H Tsukamoto, K Nagafuji, T Horiuchi, T Miyamoto, K Aoki, K Takase, H Henzan, D Himeji, T Koyama, K Miyake, Y Inoue, H Nakashima, T Otsuka, Y Tanaka, K Nagasawa, M Harada
• Risk factors for progression of tibiofemoral osteoarthritis: an analysis based on fluoroscopically standardised knee radiography (15 September, 2005)

  S A Mazzuca, K D Brandt, B P Katz, Y Ding, K A Lane, K A Buckwalter
• Prevalence and risk factors for joint pain among men and women in the West of Scotland Twenty-07 study (26 August, 2005)

  J Adamson, S Ebrahim, P Dieppe, K Hunt
• Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis (17 August, 2005)

  D Paran, J Chapman, A D Korczyn, O Elkayam, O Hilkevich, G B Groozman, D Levartovsky, I Litinsky, D Caspi, Y Segev, V E Drory
• Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis (26 August, 2005)

  K Larsson, D Mellström, C Nordborg, A Odén, E Nordborg